Reporting in Science Translational Medicine, researchers write that neural stem cell implants were able to slow the onset of amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, in mice. Study author Evan Snyder discusses the stem cells’ protective effect, and why human trials may not be far behind.
Evan Snyder is director of the Stem Cell Research Center at the Sanford Burnham Medical Research Institute in La Jolla, California.
Meet the Producer
About Christopher Intagliata@cintagliata
Christopher Intagliata was Science Friday’s senior producer. He once served as a prop in an optical illusion and speaks passable Ira Flatowese.